Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

The FDA made a historic decision to phase out animal testing and switch to human-relevant methods in drug testing and ...

An update from Sosei Group ( ($JP:4565) ) is now available. Nxera Pharma announced that its partner, Neurocrine Biosciences, has initiated a Phase ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Despite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...